Abstract：Objective: To explore the diagnostic value of BIRADS grade combined with elastography for breast cancer. Methods: A total of 105 patients with highly suspected breast cancer admitted to our hospital from January 2020 to December 2021 were selected as the study subjects, and all patients underwent BIRADS grade and elastography examination, taking the pathological test results of patients as the gold standard to explore the diagnostic value of BIRADS, elastography and the combined application. Results: This study included a total of 105 patients and 156 lesions. Pathological examination results showed that 49 lesions were benign, including 19 cases of proliferative adenoma, 14 cases of intraductal papilloma, 11 cases of fibroadenoma, and 5 cases of mastitis. The remaining 107 lesions were malignant, including 41 cases of infiltrating carcinoma, 37 cases of infiltrating ductal carcinoma, 13 cases of ductal carcinoma in situ, 8 cases of lobular carcinoma, 4 cases of mucinous carcinoma, 2 cases of papillary carcinoma, 1 case of signet ring cell carcinoma, and 1 case of sarcomatoid carcinoma. The accuracy rate of BIRADS diagnosis for breast malignancy was 81.41%, with a sensitivity of 77.57%, a specificity of 89.80%, a positive predictive value of 94.32%, and a negative predictive value of 64.71%. The accuracy rate of elasticity imaging diagnosis for breast malignancy was 85.26%, with a sensitivity of 87.85%, a specificity of 79.59%, a positive predictive value of 90.38%, and a negative predictive value of 75.00%. The accuracy rate of combined BIRADS and elasticity imaging diagnosis for breast malignancy was 91.67%, with a sensitivity of 90.65%, a specificity of 93.88%, a positive predictive value of 97.00%, and a negative predictive value of 82.14%. The accuracy of combined diagnosis was higher (91.67%) than BIRADS (81.41%) and elastography (85.26%), with statistically significant (P<0.05). Conclusion: BIRADS and elastography combined diagnosis can improve the diagnostic accuracy, specificity and sensitivity of malignant breast lesions, and have high diagnostic value.
李萍, 盛文伟. BIRADS 联合弹性成像对乳腺癌的诊断价值分析[J]. 河北医学, 2023, 29(10): 1664-1668.
LI Ping, SHENG Wenwei. Analysis of Diagnostic Value of BIRADS Combined with Elastography for Breast Cancer Diagnosis. HeBei Med, 2023, 29(10): 1664-1668.
[1] Golatta M,Pfob A,C Busch,et al.The potential of combined shear wave and strain elastography to reduce unnecessary biopsies in breast cancer diagnostics - an international,multicentre trial[J].European Journal of Cancer,2022,161(8):1-9. [2] 牛彤旭,王张,宝鲁日,等.UCH-L3和HIF-1α在乳腺良恶性病变中的表达和临床意义[J].海南医学院学报,2021,27(3):174-179. [3] Liu Q,Tang L,Chen M.Ultrasound strain elastography and contrast-enhanced ultrasound in predicting the efficacy of neoadjuvant chemotherapy for breast cancer[J].Journal of Ultrasound in Medicine,2022,41(9):2191-2201. [4] Wu H,Zhang S,Wang C,et al.Comparing the accuracy between shear wave elastography and strain elastography in the diagnosis of breast tumors:systematic review and meta-analysis[J].Medicine,2022,101(44):31526. [5] 李申辉,卢晓二,陈会娟,等.超声弹性成像联合彩色多普勒超声检查对乳腺肿块良恶性的诊断价值[J].医学影像学杂志,2022,32(10):1826-1829. [6] 武林松,庄浩泽,曲琪,等.超声弹性成像联合乳腺影像报告和数据系统在鉴别小乳腺癌与乳腺增生中的应用价值[J].中国医学装备,2022,19(9):71-74. [7] 郁玉文,范晓芳,康莉,等.BI-RADS分类标准与剪切波弹性成像技术在乳腺良恶性病变鉴别诊断中应用价值分析[J].临床军医杂志,2021,49(2):176-177,179. [8] 李瑞霞,刘娟,王惠,等.常规超声联合自动乳腺全容积成像及超声光散射技术对乳腺癌的诊断价值[J].临床与病理杂志,2022,42(8):1855-1861.
2023, Vol. 29 
冀公网安备13080202000677号